Artiva Biotherapeutics sets 2026 annual meeting for Sept 8; stockholder proposal deadline Aug 1

Artiva Biotherapeutics, Inc.

Annual meeting scheduled for September 8, 2026.
Stockholder proposals and nominations due by close of business on August 1, 2026.
Deadline applies to both business brought before meeting and director nominations.
Rule 14a-8 proposals for proxy inclusion also due by August 1, 2026.
Notices must be sent to Artiva's principal executive offices in San Diego.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.